AstraZeneca’s new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.
A genomics company, a crypto foundation, and the former CEO are all looking at this treasure trove of genetic data.
As Nature reports, consumer-genomics company 23andMe has filed for bankruptcy — and legal permission to auction off all of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback